Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Hannover Rück in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $117.60.
Current Consensus is
The current consensus among 3 investment analysts is to hold stock in Hannover Rück. This Moderate Buy consensus rating has held steady for over two years.
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property and casualty reinsurance solutions for agricultural, livestock, and bloodstock businesses; aviation and space businesses; catastrophe XL business; credit, surety, and political risks businesses; facultative business; and marine and offshore energy businesses, as well as insurance-linked securities and structured reinsurance. It also provides risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, the company offers group and individual retirement and lifestyle, credit life, and Takaful reinsurance products. Further, it provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is based in Hanover, Germany. Hannover Rück SE operates as a subsidiary of Talanx AG.